DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And ...
With all seven independent directors resigning from 23andMe millions of customers are questioning how the company plans to ...
Amgen's immunology drug results —The Novo Nordisk Senate hearing —Sanofi's soul-searching Read on to learn more.
Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.
Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...
All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...
The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
Usually, introductory meetings with startup executives are perfunctory and fade to irrelevance within an hour. But I still ...
Once a hot $6 billion biotech company, 23andMe is now on the verge of collapse. What could happen to the DNA data of its 14 ...